Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

A suggested modification to FIGO stage I endometrial cancer.

Aristizabal P, Graesslin O, Barranger E, Clavel-Chapelon F, Haddad B, Luton D, Darai E, Rouzier R, Koskas M.

Gynecol Oncol. 2014 May;133(2):192-6. doi: 10.1016/j.ygyno.2014.03.009. Epub 2014 Mar 12.

PMID:
24631453
2.

[Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].

Wang ZQ, Zhang Y, Wang JL, Shen DH, Mu T, Zhao X, Yao YY, Bai Y, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Jan;47(1):33-9. Chinese.

PMID:
22455691
3.

Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients.

Zhang C, Havrilesky LJ, Broadwater G, Di Santo N, Ehrisman JA, Lee PS, Berchuck A, Alvarez Secord A, Bean S, Bentley RC, Valea FA.

Gynecol Oncol. 2014 May;133(2):211-5. doi: 10.1016/j.ygyno.2014.02.025. Epub 2014 Feb 28.

PMID:
24582867
4.

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.

Gynecol Oncol. 2000 Apr;77(1):55-65.

PMID:
10739691
5.

Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma.

Panggid K, Cheewakriangkrai C, Khunamornpong S, Siriaunkgul S.

J Obstet Gynaecol Res. 2010 Oct;36(5):1044-8.

PMID:
21058438
6.

Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.

Hahn HS, Lee IH, Kim TJ, Lee KH, Shim JU, Kim JW, Lim KT.

Aust N Z J Obstet Gynaecol. 2013 Jun;53(3):293-7. doi: 10.1111/ajo.12089. Epub 2013 Apr 22.

PMID:
23600915
7.

Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?

Momeni M, Kolev V, Cardenas-Goicoechea J, Getrajdman J, Fishman D, Chuang L, Kalir T, Rahaman J, Zakashansky K.

Am J Obstet Gynecol. 2013 Jan;208(1):71.e1-6. doi: 10.1016/j.ajog.2012.10.009. Epub 2012 Oct 16.

PMID:
23099190
8.

Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer.

Matsuo K, Garcia-Sayre J, Medeiros F, Casabar JK, Machida H, Moeini A, Roman LD.

J Surg Oncol. 2015 Nov;112(6):669-76. doi: 10.1002/jso.24049. Epub 2015 Sep 22.

PMID:
26391212
9.

Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.

Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.

Gynecol Oncol. 2005 Mar;96(3):651-7.

PMID:
15721407
10.

An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.

Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani AR.

Anticancer Res. 2000 May-Jun;20(3B):1977-84.

PMID:
10928137
11.

Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.

Narayan K, Khaw P, Bernshaw D, Mileshkin L, Kondalsamy-Chennakesavan S.

Int J Gynecol Cancer. 2012 Feb;22(2):260-6. doi: 10.1097/IGC.0b013e318230c264.

PMID:
22080878
12.
13.

The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.

Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, Mychalczak BR, McKee B, Hoskins WJ, Barakat RR.

Cancer. 2002 Jul 15;95(2):316-21.

14.
15.

Impact of lymphovascular space invasion on a nomogram for predicting lymph node metastasis in endometrial cancer.

Koskas M, Bassot K, Graesslin O, Aristizabal P, Barranger E, Clavel-Chapelon F, Haddad B, Luton D, Darai E, Rouzier R.

Gynecol Oncol. 2013 May;129(2):292-7. doi: 10.1016/j.ygyno.2013.02.027. Epub 2013 Feb 26.

PMID:
23480871
16.

Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification.

Werner HM, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Amant F, Salvesen HB; MoMaTEC study group.

Gynecol Oncol. 2012 Apr;125(1):103-8. doi: 10.1016/j.ygyno.2011.11.008. Epub 2011 Nov 17.

PMID:
22100838
17.

Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers.

Altman AD, Ferguson SE, Atenafu EG, Köbel M, McAlpine JN, Panzarella T, Lau S, Gien LT, Gilks B, Clarke B, Cameron A, Nelson G, Han G, Samouëlian V, Ho TC, Louie K, Bernardini MQ.

Gynecol Oncol. 2015 Nov;139(2):268-74. doi: 10.1016/j.ygyno.2015.09.001. Epub 2015 Sep 6.

PMID:
26352641
18.

Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.

Simpkins F, Papadia A, Kunos C, Michener C, Frasure H, AbuShahin F, Mariani A, Bakkum-Gamez JN, Landrum L, Moore K, Thomas SG, Windhorn A, Rose PG.

Int J Gynecol Cancer. 2013 Jan;23(1):98-104. doi: 10.1097/IGC.0b013e318276d9b6.

PMID:
23221731
19.

The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer.

Loizzi V, Cormio G, Lorusso M, Latorre D, Falagario M, Demitri P, Scardigno D, Selvaggi LE.

Eur J Cancer Care (Engl). 2014 May;23(3):380-4. doi: 10.1111/ecc.12115. Epub 2013 Sep 23.

PMID:
24112088
20.

Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.

Dunn EF, Geye H, Platta CS, Gondi V, Rose S, Bradley KA, Anderson BM.

Gynecol Oncol. 2014 Jun;133(3):494-8. doi: 10.1016/j.ygyno.2014.03.554. Epub 2014 Mar 20.

PMID:
24657301

Supplemental Content

Support Center